Len Kanavy
Director/Board Member chez MERUS N.V.
Fortune : - $ au 31/03/2024
Profil
Len Kanavy is an Independent Non-Executive Director at Merus NV and a Director at KMK Consulting, Inc. He was previously a Director at the Genentech Access To Care Foundation, the Genentech Patient Foundation, and Senior VP-Commercial Business Operations at Genentech, Inc. He also held the position of Vice President-Commercial Operations at Novartis Pharmaceuticals BV.
Kanavy received his undergraduate degree and MBA from the University of Scranton.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
MERUS N.V.
-.--% | 08/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Len Kanavy
Sociétés | Poste | Début |
---|---|---|
MERUS N.V. | Director/Board Member | 01/07/2018 |
KMK Consulting, Inc.
KMK Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services KMK Consulting, Inc. delivers integrated, business-critical research, commercial analytics, and software for the pharmaceutical industry. The private company is based in Morristown, NJ. Partnering with KMK can aid in the commercialization journey. | Director/Board Member | 01/10/2017 |
Anciens postes connus de Len Kanavy
Sociétés | Poste | Fin |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/08/2016 |
Genentech Patient Foundation | Director/Board Member | 01/01/2016 |
Genentech Access To Care Foundation | Director/Board Member | 01/01/2016 |
Novartis Pharmaceuticals BV
Novartis Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals BV is a Dutch company that manufactures pharmaceutical products. The private company is based in Arnhem, Netherlands. | Corporate Officer/Principal | - |
Formation de Len Kanavy
University of Scranton | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
MERUS N.V. | Health Technology |
Entreprise privées | 5 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Novartis Pharmaceuticals BV
Novartis Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals BV is a Dutch company that manufactures pharmaceutical products. The private company is based in Arnhem, Netherlands. | Health Technology |
Genentech Access To Care Foundation | |
KMK Consulting, Inc.
KMK Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services KMK Consulting, Inc. delivers integrated, business-critical research, commercial analytics, and software for the pharmaceutical industry. The private company is based in Morristown, NJ. Partnering with KMK can aid in the commercialization journey. | Commercial Services |
Genentech Patient Foundation | Miscellaneous |